LOCALLY ADVANCED GASTRIC ADENOCARCINOMA
Clinical trials for LOCALLY ADVANCED GASTRIC ADENOCARCINOMA explained in plain language.
Never miss a new study
Get alerted when new LOCALLY ADVANCED GASTRIC ADENOCARCINOMA trials appear
Sign up with your email to follow new studies for LOCALLY ADVANCED GASTRIC ADENOCARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Custom-Made cancer vaccine shows promise in advanced tumors
Disease control Recruiting nowThis study tests a personalized vaccine made from a patient's own tumor proteins, given alone or with the immunotherapy drug pembrolizumab. The goal is to see if the combination is safe and helps the immune system attack advanced solid tumors. About 132 people with various advanc…
Matched conditions: LOCALLY ADVANCED GASTRIC ADENOCARCINOMA
Phase: PHASE1, PHASE2 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC
-
Arterial chemo combo shows promise in stomach cancer trial
Disease control Recruiting nowThis phase 3 trial tests whether giving chemotherapy directly into the artery (instead of through a vein) along with immunotherapy can better shrink locally advanced stomach cancer before surgery. About 190 participants will receive either the standard chemo regimen or the arteri…
Matched conditions: LOCALLY ADVANCED GASTRIC ADENOCARCINOMA
Phase: PHASE3 • Sponsor: Zhejiang University • Aim: Disease control
Last updated Jun 27, 2026 13:06 UTC
-
Immunotherapy duo aims to shrink stomach tumors before surgery
Disease control Recruiting nowThis Phase 2 trial tests whether adding an immunotherapy drug (QL1706) to standard chemotherapy before and after surgery can improve outcomes for people with locally advanced stomach or gastroesophageal junction cancer. About 96 participants will be randomly assigned to receive e…
Matched conditions: LOCALLY ADVANCED GASTRIC ADENOCARCINOMA
Phase: PHASE2 • Sponsor: Shandong Provincial Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:24 UTC
-
New triple therapy aims to shrink stomach tumors before surgery
Disease control Recruiting nowThis study tests a new approach for people with locally advanced stomach or gastroesophageal junction cancer. Before surgery, patients receive low-dose radiation, an immunotherapy drug (tirelizumab), and chemotherapy (SOX). The goal is to see if this combination can completely el…
Matched conditions: LOCALLY ADVANCED GASTRIC ADENOCARCINOMA
Phase: PHASE2 • Sponsor: Shandong Provincial Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:24 UTC
-
Heated chemotherapy after stomach cancer surgery: a new hope?
Disease control Recruiting nowThis phase 3 trial tests whether adding heated chemotherapy (HIPEC) directly into the abdomen after stomach cancer surgery can help patients live longer and prevent cancer from coming back in the belly. About 616 adults with advanced stomach cancer will be split into two groups: …
Matched conditions: LOCALLY ADVANCED GASTRIC ADENOCARCINOMA
Phase: PHASE3 • Sponsor: The Affiliated Hospital of Qingdao University • Aim: Disease control
Last updated Jun 27, 2026 09:11 UTC
-
New drug combo targets Hard-to-Treat stomach cancer in early trial
Disease control Recruiting nowThis phase 2 trial is testing whether adding the drug IBI363 to standard chemotherapy can improve outcomes for people with a specific type of locally advanced stomach or gastroesophageal junction cancer (MHC-II-negative). The study will enroll 60 participants who will receive the…
Matched conditions: LOCALLY ADVANCED GASTRIC ADENOCARCINOMA
Phase: PHASE2 • Sponsor: Zhejiang Cancer Hospital • Aim: Disease control
Last updated Jun 27, 2026 08:09 UTC